Study on the Characteristics of Non-targeted Metabolomics and EEG of Delayed Neurocognitive Recovery in Elderly Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Delayed Neurocognitive Recovery
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- T-MoCA (The telephone MoCA)
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Perioperative neurocognitive disorder (PND) refers to a broad range of postoperative cognitive complications, including preoperatively diagnosed cognitive decline, postoperative delirium (POD), delayed neurocognitive recovery (dNCR), and neurocognitive disorders . Among them, dNCR refers to a decline in cognitive function that occurs approximately 1-4 weeks after anesthesia/surgery in elderly patients. It is associated with an increased risk of postoperative complications and an increased length of hospital stay.
The identification of potential predictive biomarkers would be beneficial for determining the individual risk of developing dNCR and for postoperative management of elderly patients. Although some predictive markers for PNDs, such as inflammatory factors, tau protein, S100B protein, neuron-specific enolase, and brain-derived neurotrophic factor, are widely known, most of them are postoperative predictive markers. The markers that can be used to predict PNDs before anesthesia/surgery are still largely unknown.
Preoperative markers allow us to identify individuals who are susceptible to dNCR and intervene early. It is unclear whether the metabolic status of preoperative patients is related to the occurrence of postoperative cognitive dysfunction (POCD). In the framework of systems biology based on genome, transcriptome, proteome, and metabolome, metabolomics is the closest to biological phenotypes because it reflects biological events that have occurred in living organisms. Considering that metabolome reflects the metabolites of all biochemical reactions that have already taken place in an organism and contains a huge amount of information about an organism's health, preoperative patient metabolites may be a useful predictive biomarker. In this study, we used serum metabolomics to develop non-invasive, easily detectable, and inexpensive preoperative biomarkers from patient blood to determine the individual risk of dNCR and the relationship between metabolic system abnormalities and the pathogenesis of dNCR.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Gender: no gender limit
- •65 years or older .
- •Complete the operation in our hospital
- •ASA classification I-II level
- •Agree to participate in this research and agree to sign an informed consent form
Exclusion Criteria
- •History of preoperative psychosis and psychotropic drug use
- •The subject is diagnosed with AD;
- •Abnormal preoperative mental scale assessment
- •Have a history of emergency rescue during the perioperative period
Outcomes
Primary Outcomes
T-MoCA (The telephone MoCA)
Time Frame: 30 day after surgery
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.
MOCA (Montreal Cognitive Assessment)
Time Frame: right before surgery
MOCA sacle score,baseline
MMSE (mini-mental state examiniation)
Time Frame: right before surgery
MMSE scale score, baseline
Secondary Outcomes
- Self-rating depression scale(right before surgery)
- 3D-CAM(1 day after surgery)
- Self-Rating Anxiety Scale(right before surgery)